Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Vascular Diseases 1Rectal Neoplasms 1Precancerous Conditions 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Heart Diseases 1Fibrosis 1Fatigue 1Erectile Dysfunction 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1Brain Neoplasms 1Adenomatous Polyps 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Vitamin E × Clear all
NCT00096356 2021-09-29

CoQ10

Wake Forest University Health Sciences

Phase 1 Completed
236 enrolled 11 charts
Breast

Breast Neoplasms, Fatigue

NCT00583700 2013-01-29

Trental & Vitamin E for Radiation-Induced Fibrosis

University of Iowa

Phase 2 Completed
54 enrolled 7 charts
Breast

Breast Neoplasms, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡